Related Experiment Video
Updated: May 13, 2026
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Oleocanthal inhibits proliferation and MIP-1α expression in human multiple myeloma cells
1SERGAS, Santiago University Clinical Hospital Research Laboratory 9 (NEIRID LAB: Laboratory of Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases), Institute of Medical Research (IDIS), Santiago de Compostela, 15706, Spain.
Abstract:
Multiple myeloma (MM) is a plasma cell malignancy that causes devastating bone destruction by activating osteoclasts in the bone marrow milieu. MM is the second of all hematological malignancies. Thus, the search for new pharmacological weapons is under intensive investigation being MM a critically important public health goal. Recently, it has been demonstrated that macrophage inflammatory protein 1- alpha (MIP-1 α) is crucially involved in the development of osteolytic bone lesions in MM. Phenolic components of extra virgin olive oil are reported to have anti tumor activity. However, the underlying mechanisms and specific targets of extra virgin olive oil remain to be elucidated. In the present study, we investigated the effects of a recently isolated novel extra virgin olive oil polyphenol, oleocanthal, on the human multiple myeloma cell line ARH-77. Here we report that this natural compound has a remarkable in vitro activity by inhibiting MIP-1 α expression and secretion in MM cells. In addition, we also demonstrated that oleocanthal inhibits MM cells proliferation by inducing the activation of apoptosis mechanisms and by down-regulating ERK1/2 and AKT signal transduction pathways. This in vitro study suggests a therapeutic potential of oleocanthal in treating multiple myeloma.
Insights
Oleocanthal, a novel polyphenol from extra virgin olive oil, effectively inhibits multiple myeloma (MM) cell growth. This compound reduces key inflammatory markers and induces cancer cell death, suggesting its therapeutic potential for MM treatment.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Multiple myeloma (MM) is a hematological malignancy characterized by significant bone destruction.
- Osteoclast activation, mediated by factors like macrophage inflammatory protein 1-alpha (MIP-1 α), drives MM-related bone lesions.
- Extra virgin olive oil polyphenols show anti-tumor potential, but their mechanisms in MM require elucidation.
Purpose of the Study:
- To investigate the in vitro effects of oleocanthal, a novel extra virgin olive oil polyphenol, on the human multiple myeloma cell line ARH-77.
- To determine oleocanthal's impact on MIP-1 α expression and secretion in MM cells.
- To explore oleocanthal's influence on MM cell proliferation and underlying signaling pathways.
Main Methods:
- In vitro study using the human multiple myeloma cell line ARH-77.
- Assessment of MIP-1 α expression and secretion.
- Analysis of cell proliferation, apoptosis, and the ERK1/2 and AKT signaling pathways.
Main Results:
- Oleocanthal demonstrated significant in vitro activity against MM cells.
- The compound inhibited MIP-1 α expression and secretion in MM cells.
- Oleocanthal suppressed MM cell proliferation by inducing apoptosis and down-regulating ERK1/2 and AKT signaling.
Conclusions:
- Oleocanthal exhibits therapeutic potential for multiple myeloma treatment.
- Inhibition of MIP-1 α and modulation of apoptotic and signaling pathways are key mechanisms of oleocanthal's anti-myeloma activity.
- This study highlights oleocanthal as a promising natural compound for further investigation in MM therapy.
